InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 160483

Monday, 07/25/2016 9:50:52 AM

Monday, July 25, 2016 9:50:52 AM

Post# of 345747
http://www.bioworld.com/content/nucana-biomed-gets-105m-protide-cancer-drugs-1
Another 6 degrees of separation becoming closer.... as we have pro-tide developer Chris M. BOD at Inhibitex ...such a small world now, especially with the alignment of opposers against Peregrine Pharmaceuticals

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News